Brands and Products
Chemours uses the power of chemistry to create better, reliable solutions.
The future of transport is here.
Discover how Chemours is driving innovation in the Electric Vehicle space with our latest line of advanced performance materials.
Sustainability
Creating a better world through responsible chemistry.
Our 2030 Goals
Our progress towards achieving Chemours’ Corporate Responsibility Commitment goals
Critical Chemistries
Chemours is working to create a better world through the power of our chemistry.
Showing 221-230 of 267 results
Government Officials Hail Decision as a Major Economic and Academic Development Win for the State The Chemours Company ( Chemours ) (NYSE: CC) is pleased to announce it has entered into an agreement to build a state-of-the-art research and innovation facility on the University of Delaware's Science, Technology and Advanced Research (STAR) Campus.
The Chemours Company ( Chemours ) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts, and chemical solutions, announced today that its President and CEO, Mark Vergnano , has been elected to chair the board of the National Safety Council (NSC).
Chemours supports EPA's authority under the Clean Air Act to change the status of high-GWP alternatives to unacceptable The Chemours Company ( Chemours ) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, expresses its disappointment with the decision by the U.S.
The Chemours Company ( Chemours ) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today that the Board of Directors of Chemours declared a quarterly cash dividend of $0.03 per share on the company's common stock for the third quarter of 2017.
Second Quarter 2017 Highlights Net Sales of $1.6 billion , up 15% Net Income of $161 million , up $179 million with EPS of $0.84 , up $0.94 per diluted share Adjusted EBITDA of $361 million , up $174 million , driven by strong year-over-year volume and price improvement in Titanium Technologies and Fluoroproducts Adjusted Net Income of $166 million , up $117 million with Adjusted EPS of $0.87 , up...
The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today that the U.S. EPA Significant New Alternatives Policy (SNAP) program has listed low global warming potential (GWP) refrigerants Opteon™ XP44 (R-452A), Opteon™ XP40 (R449A), and Opteon™ XP10 (R-513A) as acceptable for use. The U.S. EPA SNAP program supports the transition away from ozone-depleting compounds.
The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announces the first sales of Opteon™ YF (R-1234yf) 12oz service cans in the United States.
The Chemours Company ( Chemours ) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, today, announced the pricing of the previously announced registered underwritten public offering (the "offering") of $500,000,000 in aggregate principal amount of 5.375% senior notes due 2027 at a public offering price of 99.051% of...
The Chemours Company ( Chemours ) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, today announced that it intends to offer (the "offering") $500,000,000 aggregate principal amount of senior notes due 2027, subject to market and other conditions.
First Quarter 2017 Highlights Net Sales of $1.4 billion , up 11%, including impacts from divestitures Net Income of $150 million , up $99 million with EPS of $0.79 , up $0.51 per diluted share Adjusted EBITDA of $285 million , up 123%, demonstrating margin improvement across all segments Adjusted Net Income of $142 million , up $131 million with Adjusted EPS of $0.75 , up $0.69 per diluted share A...